Specialty pharmacy and infusion services with home delivery and medication management
AmeriPharma operates four clinical divisions—specialty pharmacy, infusion therapy, medication packaging, and home nursing care—serving patients with complex conditions across multiple disease states. The hiring surge (52 new roles in 30 days, 75% healthcare-focused) combined with active projects in security monitoring, claims automation, and payer workflows signals rapid operational scaling. Pain points around HIPAA compliance, data breach prevention, and billing modernization indicate the company is investing heavily in backend infrastructure to match clinical growth.
Notable leadership hires: Billing Director
AmeriPharma is a specialty pharmaceutical services provider founded in 2006, headquartered in Orange, California, and operating four integrated divisions. Specialty Care serves patients with autoimmune, genetic, and complex diseases through accredited pharmacy and clinical support. The Infusion Center offers in-facility IV therapy under nursing supervision. MedBox packages and delivers multi-medication regimens directly to patients. CorsanaCare provides home-based infusion nursing. The company works across disease areas including multiple sclerosis, cystic fibrosis, transplants, Crohn's disease, and hemophilia, collaborating with doctors, manufacturers, and insurance companies.
Cloud infrastructure on AWS, Azure, GCP with data warehousing via Citus and AWS RDS. Analytics via Tableau, Power BI, Looker Studio. HR/payroll through Paychex and ADP. Healthcare-specific: Availity, Waystar, Brightree for claims and payer integration. Logistics via FedEx and UPS systems.
Orange, California. Founded in 2006 as a privately held company with all current hiring concentrated in the United States.
AmeriPharma's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.